MedTrace Logo

Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy

NCT03763266 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 858

Last updated 2020-02-12

No results posted yet for this study

Summary

Colonoscopy is the gold-standard for the evaluation of the colorectal mucosa. Colonoscopy quality indicators are the adenoma detection rate, the rate of cecal intubation and the bowel preparation.

The role of diet in preparing for colonoscopy is not fully established. Currently there is not enough evidence available to choice between 3 days of low residue diet versus 1 day.

The research hypothesis is that the low residue diet offers a non-inferior bowel preparation and an improved tolerance.

Conditions

  • Colonoscopy
  • Colon Adenoma
  • Colorectal Neoplasms
  • Inflammatory Bowel Diseases
  • Colon Disease

Interventions

OTHER

1 day low residue diet

Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.

OTHER

3 day low residue diet

Patients are interviewed and instructed by a nurse prior the colonoscopy. They receive oral and written dietary information. In case of morbidity associated with bad preparation they are given bisacodyl the night before the colonoscopy.

Sponsors & Collaborators

  • Parc Taulí Hospital Universitari

    lead OTHER

Principal Investigators

  • Eva Martínez, PhD · Corporació Sanitaria Parc Taulí

  • Salvador Machlab, MD · Corporació Sanitaria Parc Taulí

  • Rafel Campo, PhD · Corporació Sanitaria Parc Taulí

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-06
Primary Completion
2019-11-10
Completion
2020-01-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03763266 on ClinicalTrials.gov